Overview

Improving HbA1c Levels by Methylcobalamin Vitamin in Diabetic Volunteers

Status:
COMPLETED
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
The current study was conducted to evaluate the prognostic implications of vitamin B12 admission on BMI and HbA1c levels in type 2 diabetic patients treated with Dapagliflozin as a routine medication.
Phase:
NA
Details
Lead Sponsor:
Al-Balqa Applied University
Treatments:
dapagliflozin
Vitamin B 12